JPS5953425A - Vaginal lubricant - Google Patents

Vaginal lubricant

Info

Publication number
JPS5953425A
JPS5953425A JP57163830A JP16383082A JPS5953425A JP S5953425 A JPS5953425 A JP S5953425A JP 57163830 A JP57163830 A JP 57163830A JP 16383082 A JP16383082 A JP 16383082A JP S5953425 A JPS5953425 A JP S5953425A
Authority
JP
Japan
Prior art keywords
vagina
whey
bacteria
microbial flora
humectation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57163830A
Other languages
Japanese (ja)
Inventor
Takeshi Niikubo
新久保 健
Tsutomu Yuhara
湯原 力
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Dairies Corp
Original Assignee
Meiji Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Milk Products Co Ltd filed Critical Meiji Milk Products Co Ltd
Priority to JP57163830A priority Critical patent/JPS5953425A/en
Publication of JPS5953425A publication Critical patent/JPS5953425A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PURPOSE:To provide the titled agent useful for the normalization of the microbial flora in vagina and the humectation and lubrication of vagina, by using whey or its treated material as an active component. CONSTITUTION:The agent contains whey or its treated material as an active component. The bacteria in the vagina are composed mostly of doederlein vaginal bacili having the physiological protective mechanism and the self-cleaning activity to protect the upper genitalia from infection with bacteria; however, the microbial flora in the vagina sometimes becomes to an undesirable state after menopause, etc. Further, a mucous liquid is secreted in the vagina generally by the effective sexual stimulus to facilitate the coitus; however, one may feel the difficulty, etc. in the coitus by the insufficient secretion caused by various external conditions and age, etc. It has been found that whey is effective for the normalization of the microbial flora in the vagina and the humectation and lubrication of the vagina. The whey includes any wheys such as the one obtained by adding an acid to milk, and separating the coagulated product. The prepared whey is absorbed in a tampon, and used as an insertion agent.

Description

【発明の詳細な説明】 本発明は膣内の清浄化乃至は湿潤消化に有効な剤に関す
るものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an agent effective for vaginal cleansing or moist digestion.

更に詳細には、本発明はポエイもしくけその処理物をイ
j幼成分とする膣湿狂1滑剤に関するものである。
More specifically, the present invention relates to a vaginal moisturizing lubricant containing poei or a processed product of poei as a sexual component.

一般に、膣壁枯1模の代謝t」卵巣ホルモンが関与し、
特にニストロジエンに支配されている1、性的に静市状
態にある幼児・少な期の粘膜は薄く、思春回の性ホルモ
ンI’i’i動が盛んになると、紳士皮層1厚< 兄W
 l−、て、以降性成熟期を1tuじニストロジエンが
十分に分泌されておれば、膣は生〕」的に防1ii(l
 4i% t^゛(を山し、膣を漬汁かつ匪康に保つば
かりでなく、膣内に14人する病原菌、偵1.閑の発育
を1M4止し7、上部性器(子宮、卵管)の細+’tT
 を引1νを防ぐ作用を有している。これを膣の自r7
+作L1.Iというが、これは、性成熱間における1障
士皮は肥厚と同時に上皮細胞中にダリコーゲ゛ンを含有
するが、剥脱された上皮卸1j抱内のグリコーゲ゛ンは
4J7!化酵素によって分解され、その分解産物Jであ
るノドウ1+Q &:l: 、膣内細菌の作用によって
乳酸を産生’J’ Z) r+その結果、膣内Ni I
&は上昇し、非病原性のデーデルラインlI’M什菌の
発育に好都合な結果となり、結J、17的に4゛1ト菌
や病原菌を死滅さ−けることになる。
In general, ovarian hormones are involved in the metabolism of vaginal wall dryness,
In particular, the mucous membrane of infants and young children who are in a state of sexual quiescence, which is controlled by nistrogien, is thin, and when the sex hormone I'i'i movement during puberty becomes active, the thickness of the men's cortical layer becomes less than 1 thick.
After sexual maturation, if enough nistrogien is secreted, the vagina becomes naturally protective.
It not only keeps the vagina juicy and healthy, but also prevents the growth of 14 pathogenic bacteria in the vagina. )'s thin+'tT
It has the effect of subtracting 1ν and preventing it. This is my vagina r7
+Made L1. This means that during sexual growth, the skin of a disabled person thickens and at the same time contains dalicogen in the epithelial cells, but the amount of glycogen in the exfoliated epithelium is 4J7! The decomposition product J is the decomposition product J, and lactic acid is produced by the action of intravaginal bacteria.
& increases, which favors the growth of non-pathogenic Daederlein's microorganisms, and ultimately kills 4.1 microorganisms and pathogenic microorganisms.

Bergey’s Manual (194B)によれ
ば、この菌群中に、Bacillus vaginae
 、 H,vaF由tal is −1o+g+s 、
 H,vp)<1nalis 。
According to Bergey's Manual (194B), this bacterial group includes Bacillus vaginae.
, H, vaF tal is -1o+g+s,
H,vp)<1nalis.

Ac 1dol)aCteriu+n doederl
 i++ic 、 Lactobac i l lus
 −t18+Ierlei n 。
Ac 1dol) aCteriu+n doederl
i++ic, Lactobacillus
-t18+Ierlein.

L、 acidophi lns  などが含むとされ
でいた。
L., acidophylns, etc. were said to be included.

1960年、1ぐ0GO8Aが21名の肚硯な婦人の膣
内菌を調査[7、乳酸杆菌を65株分1’if[1〜、
このうち21株について分類した結果(残り14株V1
死i)、14株がL acidol+hilus 、2
什がIJ、CRRelvar rb+nunn8us 
、 4株がL−formcnti 、  1抹がり。
In 1960, 1GO8A investigated the vaginal bacteria of 21 insecure women [7, 65 strains of Lactobacillus 1'if[1~,
As a result of classifying 21 of these stocks (remaining 14 stocks V1
death i), 14 strains are Lacidol + hilus, 2
The other is IJ, CRRelvar rb+nunn8us
, 4 strains were L-formcnti, 1 strain.

celloMos++s  −Cあ−)だ事実から、デ
ーデ、lレライン膣杆菌はり、 acidoi+hi 
lus f:主体とする乳酸杆閑叶であるとした。(J
、 gen 、 IVHcrnhiol 25197)
 iた、Bt!rgey’s Marmal の第8版
で・もこれが採用されている。
From the fact that celloMos++s -Ca-), Dede, lreline vaginal rod bacteria, acidoi+hi
lus f: It was assumed that the main ingredient was lactic acid. (J
, gen, IVHcrnhiol 25197)
It was, Bt! This is also adopted in the 8th edition of rgey's Marmal.

このように、膣内の+j、lll l!jは、はとんど
このデーデルラインIFn杆菌で占めるか、あるいは、
わずかに110の非チ丙原住の細菌が混じている状態と
なる。
In this way, +j in the vagina, lll l! j is mainly occupied by this Daederlein IFn rod, or
Only 110 non-Chihei native bacteria were mixed in.

更に、出生時、膣内r[無菌的であるが、短時間に細[
頁の浸入を・妥・け、史に2〜6週間経過するとデーデ
ルライン什菌群に変り、その後、思春期になる邊でこの
閑H1に球菌、連鎖状球菌、コリネ/くクテリウムPA
+慴などが加4つり、これらが優勢に増殖してくる。初
潮前に、この両相は丙び変化[7て乳酸杆α4が優勢と
なり、以後紺、続して孔版を生成し、感染防御因子の1
つとして役立つよりになる。
Furthermore, at birth, intravaginal r [sterile, but in a short period of time]
After the infiltration of the page, after 2 to 6 weeks, it changes to Daederlein's bacteria group, and then, at the age of puberty, cocci, streptococci, coryneformes/cacteria, etc.
+慴 etc. are added, and these are dominantly proliferating. Before menarche, these two phases undergo a gradual change [7], and lactobacillus α4 becomes predominant, then dark blue, then stencil, and infection-protective factor 1.
It will be more useful than ever.

しかり1.なから、閉経ル1に錦すると再び変化し、思
祥間と同様、球菌、連釦状球閑を宮む混合両相に変化L
 、史に&−,1−,lk’(内が好−ましくない四相
になつ℃しまうこともある。
Reprimand 1. Therefore, when Nishiki enters menopause L 1, it changes again, and changes to a mixed phase containing cocci and continuous button-shaped bulbs, just like in Sishoma.
, in the history &-, 1-, lk' (inner may become unfavorable four-phase °C).

−:jj X 畠l1Ili化it余への会、連な、随
すに伴なって、加齢と11機能の問題が話題となってい
るが、千J1以外にも、ストレスや情報過多、過程R”
i ’、’F Kよる心因性インポテンツの増加前で、
性医学に利する関心か1;哉を日用にも而まってきてい
る。
-: jj R”
i', 'F Before the increase in psychogenic impotence due to K,
Is it because of interest in sexual medicine?

一般に、有効な性的刺戟が加えら、fLlj隙、肝内に
粘?l’t tlkが分aされ、性行為を円t1tに1
′るのであるが、その粘滑沿は、バルトリン腺、1:り
内分泌d2髪がその7定目を果しでいるものと−3え1
′つJlでい/(1、ところが最近の知見によると、バ
ルトリンl’l J:りの分泌液な1.1〜4 M物+
ii度で、ll’# %二訓すにit至らず、その主役
は1膣を取巻く静脈が拡張し、それからしみ出I7た1
)11出沿であるとはhてきた。
In general, if effective sexual stimulation is added, fLlj gap, viscous in the liver? l't tlk is divided into a sex act in a circle t1t
However, its viscous line is similar to that of the Bartholin gland, which fulfills its seventh function.
``Tsu Jl / (1, However, according to recent findings, Bartholin l'l J: Ri's secretion 1.1-4 M +
At the 2nd degree, the main character is the dilation of the veins surrounding the vagina and the exudation of I7 from it.
) 11 has arrived.

しかしながら、各種外的要因や年齢などによって、l’
l興奮時の分泌物不足によるIIF行為の口重、It 
(’4:がみらiするなと、新た乃′問題が]j〆起さ
力て久しい。
However, due to various external factors, age, etc.
l Difficulty in performing IIF acts due to lack of secretions during excitement, It
('4: Don't do it, there's a new problem] It's been a long time since I've had a problem.

本発明者らは、膣内の菌相の王宮化及び湿旧1H4什を
求めてイυ)梵(、、た結果、ホエイもり、 < 1、
その処理物を有効成分とすることによって仁71をI’
l’l’ ?、1.1. ’ Jることかできた。
The present inventors sought to royalize the bacterial flora in the vagina and reduce the amount of moisture in the vagina.
By using the treated product as an active ingredient, I'
l'l'? , 1.1. 'I was able to say J.

本発明はホエイも17<はぞの処1jl!q勿をイj効
Jlk力とする膣湿市1滑剤に関するものである0本妃
明に使用するホエイとは、牛乳に酸を添加して、凝固物
を分gn6 +、て得られたホエイ、牛乳にレンネット
をt1Σ加して凝固させ、分離したホエイ、牛乳に乳酸
菌を培養し、凝固物を分離したホエイ等あらゆるポエイ
を含んでいる。
The present invention also uses whey 17<Hazonodokoro1jl! The whey used in this product is the whey obtained by adding acid to milk and dividing the coagulate. It contains all kinds of poei, such as whey that is separated by adding rennet to milk for t1Σ and coagulating it, and whey that is obtained by culturing lactic acid bacteria in milk and separating the coagulated product.

酸添加のにiA合は、牛乳に1M酸、乳酸等の1f、を
帛加してpII= 4.6程展にしてしばらく放1aす
るとk<iJs物が沈殿するので、上清をホエイとして
分離することができる。
In the case of adding acid, add 1M acid, lactic acid, etc. to milk and make it expand to about pII = 4.6. If you leave it for a while, k<iJs will precipitate, so use the supernatant as whey. Can be separated.

し/ネットの65加の場合は、50℃程度にした牛乳に
100万単位のレンネットを数al / kg程黒]t
!11加して、1〜6時間時間数16′シてわ・〈と凝
集物が沈殿するので十fI’rをホエイとして分離する
ことができる。
In the case of 65% net/net, add 1,000,000 units of rennet to milk heated to about 50°C and add several al/kg of black]t
! In addition, for 1 to 6 hours, the aggregates precipitate and can be separated as whey.

乳「1安菌を培養する1易合l−[、牛乳に各棹乳岐菌
スターターを添加(7て25〜65℃程度で培養し、1
+l(= 5.2程I現になるとカードの凝來か起るの
でこれを分離してホエイを得ることができる。特)(乳
酸菌の中でも、ラクトノシチルス・ニーグリティ黒85
1、li”ER+νl  PA5851  を使用する
と発酵乳が粘性を帯ひるため、増粘剤の添加を必快とし
ないなどすぐれたホエイを得ることができる。
Add each milk starter to milk (incubate at 25-65°C,
+l (= 5.2) As the curds congeal, it can be separated to obtain whey. (Special) (Among lactic acid bacteria, Lactonocylus nigriti black 85
1. When using li"ER+vl PA5851, the fermented milk becomes viscous, so it is not necessary to add a thickener, and excellent whey can be obtained.

このようにして得られたホエイt[、その゛ま捷で使用
することもできるが、これをθ++BM(、たり、“ま
たt1蛋自分’p+’t t’+≠素で分νyr処理し
たり、史にe、1、仁の分力11沿を・苺算稲したりす
ることができる。
The whey obtained in this way can be used as it is, but it can also be treated with , history, e, 1, jin's component power 11 can be calculated.

蛋白分解酵素処理においては、ホエイの1)11が4〜
5であるため、例えば、プロクター−ビ(明治製菓)、
モルシン(瘤進製桑)などの+lbt Iqv i’!
i ;、1白質消化酵素剤の使用が好ましい。これら「
・h素削11ポエイ中にごく少歇、例えば5〜i o 
o my%稈1(冷JJn L、、55〜55℃程1現
に脚幅すれば5〜20時間程IJjで蛋白質が分hイさ
れる。
In the proteolytic enzyme treatment, 1) 11 of whey is 4~
5, so for example, Proctorbi (Meiji Seika),
+lbt Iqv i' such as Morsin (Kusshin Mulberry)!
i;, 1 It is preferable to use a white matter digestive enzyme agent. these"
・Very few moments during h drafting 11 poei, for example 5~i o
o my% culm 1 (cold JJn L), if heated to about 55 to 55°C, the protein will be separated for about 5 to 20 hours.

酵素分解によって蛋白質は低分子−くブタイドお、Lひ
アミノ酸に゛まで分1111トして、デー−y’ tr
yライン+I′l′r什菌の生付に好(its台な栄誉
外となる3、捷た、一般に蛋白質のj孝索分l・遅は 
11.+’(壁よりの吸11ツカt1強いので、41(
白υlによるアレルギーを予防する上からも有効である
。更に、最終工程にお&Jるター]・り【/−ブト■作
のに六用溶1″1缶11′員であるアルブミンやクロプ
リンが残存していると、熱凝f、!、Jをおこして沈殿
することがあるので、それを防止する上からも−6−効
である3、 このようにしてイJiら7またホエイ又e1ホエイ処理
′吻は浸透圧を調整することが好ましい。血清の浸透圧
は275〜290 mOsm/Lで本るが、本市では膣
内で希釈されることも瑚慮に人i1て、300〜40 
D rn Osm/’t lA#がi内当である。
By enzymatic decomposition, proteins are reduced to 1111 low-molecular-weight butide and L-amino acids, resulting in data-y' tr
y line + I'l'r is good for the growth of bacteria (its level is out of honor 3, it is broken, and generally the protein's filtrate is
11. +'(The suction from the wall is 11 t1 stronger, so 41(
It is also effective in preventing allergies caused by white υl. In addition, if albumin or clopurine, which is a member of the 11'11'-membered solution, remains in the final process, thermal condensation f,!,J will occur. In this way, it is preferable to adjust the osmotic pressure of whey or e1 whey treatment. The osmotic pressure of serum is 275-290 mOsm/L, but in this city it is 300-40 mOsm/L, considering that it is diluted in the vagina.
DrnOsm/'tlA# is i-approved.

ホエイ又はホエイ処理物はCMCやアルギン酸すl・リ
ウムなと 炭水化物系の糊料を加え、粘度を150〜6
0 D cps稈曵になるように調整式れるのが好−憂
し7い。
For whey or whey processed products, add carbohydrate-based thickeners such as CMC, sl/lium alginate, etc., and reduce the viscosity to 150-6.
I like that it can be adjusted so that it becomes a 0D cps culm.

iu・’J ’IP物V1タンポンに吸+l’xaせて
仲人剤にしたり、史に枯腹を高めて塗布ハ11にしたり
、カプセルにつめて坐削Kt、Lりすることができる。
iu・'J' You can use it as a go-between by adding it to an IP V1 tampon, or you can use it to increase your hunger and apply it to 11, or you can put it in a capsule and use it for sitting.

(にに本つヘ明の実施レリを示ず。(I do not show the actual implementation of this book.

実61ij lタリ 牛乳に、脱tltr ′i′1.で培養したシフトバチ
ルス・ニークルティA 851 、FM引?M−PA 
5 (451のスターターを10%添加し、so℃で1
0時間酊1ど「培養した陵、遠心分Pri#シ、約50
%の11v率でホエイをイ:すた。
Fruit 61ij l tari milk, detltr 'i'1. Shift Bacillus niculutii A 851 cultured in FM-pulled? M-PA
5 (added 10% starter of 451 and heated at 1°C at
0 hour drunkenness 1 degree "Cultured ribs, centrifuged minute Pri#shi, approx. 50
% of whey at 11v rate.

得られたポエイを50℃に保持(,7て、15h72≠
の面1酸性蛋白分解酵素剤(七リシン)をTA口+u 
I−、。
The obtained poei was kept at 50°C (,7,15h72≠
Side 1 Add acidic proteolytic enzyme agent (Septilysine) to TA port + u
I-,.

3時11旧1を拝して分解処Jil l、だ。At 3:11, I worshiped the old 1 and disassembled it.

州らi]た処理液を9 (] C15分間処坤1−.、
f・酉((失活させ、こJlに乳糖を添hu L、浸透
片が3511tn (、) S 171 /ノにlるよ
うにi!At 幣した。
1-. Treat the treatment solution for 15 minutes.
F. Rooster (((Inactivated), added lactose to this Jl, and poured it so that the permeation piece was 3511tn (,) S 171 /ノ.

f4 x?in1.1j17,1整物にC〜ic −N
aを1.5 %添加し、よく4り押漬(出来−1:り粘
11(200raps) N−汁熱性容詣に分注し、オ
ートクレーブで121℃: 155jitillII2
菌処川1し、解り一1閏滑j″(11を1:また。
f4 x? in1.1j17,1 C~ic -N
Add 1.5% of a and press well 4 times (done - 1: viscosity 11 (200 raps)) N-Soup dispensed into a thermoplastic container and autoclaved at 121℃: 155jitillII2
The fungus is 1, and the 11 is 1, and the 1 is 1: again.

Claims (1)

【特許請求の範囲】[Claims] ホエイもしくはその処理物を有効成分とする爬湿f1′
l:l滑剤0
Retsuyu f1' containing whey or its processed product as an active ingredient
l: l lubricant 0
JP57163830A 1982-09-22 1982-09-22 Vaginal lubricant Pending JPS5953425A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57163830A JPS5953425A (en) 1982-09-22 1982-09-22 Vaginal lubricant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57163830A JPS5953425A (en) 1982-09-22 1982-09-22 Vaginal lubricant

Publications (1)

Publication Number Publication Date
JPS5953425A true JPS5953425A (en) 1984-03-28

Family

ID=15781553

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57163830A Pending JPS5953425A (en) 1982-09-22 1982-09-22 Vaginal lubricant

Country Status (1)

Country Link
JP (1) JPS5953425A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001523231A (en) * 1997-04-11 2001-11-20 ジャイネロジックス インコーポレイテッド Vaginal lactobacillus drugs
EP1631243A2 (en) * 2003-04-09 2006-03-08 Dolhay Klinika Egészségügyi KFT. Sexual hygienic composition
WO2007039124A3 (en) * 2005-09-23 2007-06-28 Bionest Ltd Compositions comprising colostrum and hyaluronic acid for the treatment of vaginal dryness
RU2474417C2 (en) * 2007-06-18 2013-02-10 Дольхаи Клиника Эгесшегюдьи Кфт. Biocidal capsules containing their preparation and tampon containing preparation

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001523231A (en) * 1997-04-11 2001-11-20 ジャイネロジックス インコーポレイテッド Vaginal lactobacillus drugs
EP1631243A2 (en) * 2003-04-09 2006-03-08 Dolhay Klinika Egészségügyi KFT. Sexual hygienic composition
EP1631243B1 (en) * 2003-04-09 2013-05-15 Dolhay Klinika Egészségügyi KFT. Sexual hygienic composition
WO2007039124A3 (en) * 2005-09-23 2007-06-28 Bionest Ltd Compositions comprising colostrum and hyaluronic acid for the treatment of vaginal dryness
RU2474417C2 (en) * 2007-06-18 2013-02-10 Дольхаи Клиника Эгесшегюдьи Кфт. Biocidal capsules containing their preparation and tampon containing preparation

Similar Documents

Publication Publication Date Title
Kopeloff Lactobacillus acidophilus
US20110178488A1 (en) Sexual Hygienic Composition
Asali et al. Ritual female genital surgery among Bedouin in Israel
CN109674826A (en) A kind of probiotic composition for nursing female reproductive system
Turner Acute brachial radiculitis
JPS5953425A (en) Vaginal lubricant
Cowan Gonococcal ulceration of the tongue in the gonococcal dermatitis syndrome.
US4525351A (en) Liquid adherent disinfectant compositions for topical application and method of preparation
Vale et al. Corynebacterium bovis as a cause of human disease
Påhlson et al. The ecologically wrong vaginal lactobacilli
Gunston et al. Treatment of vaginal discharge with yoghurt
SEABURY Stilbamidine in the treatment of histoplasmosis: two case reports
MAGENDANTZ et al. Virilization during pregnancy associated with polycystic ovary disease
Douglas et al. Bacteriologic findings in the uterus during labor and the early puerperium
Blinick et al. Effect of sulfonamide cream on the bacterial flora of the infected vagina and cervix
Randall et al. Tropical inguinal granuloma in the Eastern United States
Karhunen et al. Single dose of tinidazole in prophylaxis of infections following vaginal surgery
Bassler et al. Bacillus acidophilus: its very limited value in intestinal disorders
Fox Autogenous serum in the treatment of psoriasis
STODDARD Points in technic of separating anaerobes
Catton LEUKOPENIA, ITS SIGNIFICANCE
Lucas et al. A child with acute suppurative thyroiditis
Friedman et al. Treatment of pruritus ani by local applications of aluminum hydroxide gel
Gibson et al. A Study of the Streptococci from Fifty cases of Bovine Mastitis
Castellani Case of Trichomycosis Axillaris Rubra.